Annual ROE
-35.76%
-2.27%-6.78%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual return on equity is -35.76%, with the most recent change of -2.27% (-6.78%) on September 30, 2024.
- During the last 3 years, AVXL annual ROE has fallen by -10.62% (-42.24%).
- AVXL annual ROE is now -105.59% below its all-time high of 639.63%, reached on September 30, 2011.
Performance
AVXL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-33.04%
-2.40%-7.83%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly return on equity is -33.04%, with the most recent change of -2.40% (-7.83%) on September 30, 2024.
- Over the past year, AVXL quarterly ROE has dropped by -2.40% (-7.83%).
- AVXL quarterly ROE is now -104.14% below its all-time high of 798.00%, reached on September 30, 2011.
Performance
AVXL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVXL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.8% | -7.8% |
| 3 y3 years | -42.2% | +6.3% |
| 5 y5 years | +72.4% | +6.3% |
AVXL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.2% | at low | -15.9% | +10.2% |
| 5 y | 5-year | -42.2% | +72.4% | -15.9% | +75.2% |
| alltime | all time | -105.6% | +99.3% | -104.1% | +98.4% |
Anavex Life Sciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -35.76%(+6.8%) | -33.04%(+7.8%) |
| Jun 2024 | - | -30.64%(+5.5%) |
| Mar 2024 | - | -29.04%(-4.2%) |
| Dec 2023 | - | -30.32%(-9.2%) |
| Sep 2023 | -33.49%(-0.5%) | -33.40%(-7.9%) |
| Jun 2023 | - | -36.27%(-1.4%) |
| Mar 2023 | - | -36.78%(+6.6%) |
| Dec 2022 | - | -34.50%(+6.4%) |
| Sep 2022 | -33.67%(+33.9%) | -32.43%(+7.2%) |
| Jun 2022 | - | -30.26%(+6.2%) |
| Mar 2022 | - | -28.50%(-7.7%) |
| Dec 2021 | - | -30.89%(-12.4%) |
| Sep 2021 | -25.14%(-73.9%) | -35.26%(-16.0%) |
| Jun 2021 | - | -41.97%(-35.8%) |
| Mar 2021 | - | -65.42%(-27.0%) |
| Dec 2020 | - | -89.57%(-12.5%) |
| Sep 2020 | -96.49%(-25.5%) | -102.39%(-5.5%) |
| Jun 2020 | - | -108.32%(-7.5%) |
| Mar 2020 | - | -117.09%(-12.0%) |
| Dec 2019 | - | -133.06%(-12.3%) |
| Sep 2019 | -129.60%(+67.7%) | -151.73%(+3.0%) |
| Jun 2019 | - | -147.33%(+25.9%) |
| Mar 2019 | - | -116.98%(+24.5%) |
| Dec 2018 | - | -93.98%(+27.9%) |
| Sep 2018 | -77.29%(+39.3%) | -73.47%(+4.7%) |
| Jun 2018 | - | -70.16%(-4.5%) |
| Mar 2018 | - | -73.44%(+21.0%) |
| Dec 2017 | - | -60.69%(-0.4%) |
| Sep 2017 | -55.50%(-76.2%) | -60.93%(-27.6%) |
| Jun 2017 | - | -84.16%(-14.5%) |
| Mar 2017 | - | -98.43%(-24.3%) |
| Dec 2016 | - | -130.05%(-22.4%) |
| Sep 2016 | -233.61%(+147.1%) | -167.68%(+28.6%) |
| Jun 2016 | - | -130.42%(-15.1%) |
| Mar 2016 | - | -153.69%(-10.5%) |
| Dec 2015 | - | -171.77%(-12.9%) |
| Sep 2015 | -94.53% | -197.25%(-60.9%) |
| Jun 2015 | - | -504.32%(+36.3%) |
| Mar 2015 | - | -370.04%(+37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | -269.71%(-3.0%) |
| Sep 2014 | -5175.70%(-3545.6%) | -278.07%(+74.4%) |
| Jun 2014 | - | -159.47%(-92.4%) |
| Mar 2014 | - | -2107.69%(-2129.2%) |
| Dec 2013 | - | 103.87%(-10.3%) |
| Sep 2013 | 150.21%(-48.0%) | 115.81%(+175.0%) |
| Jun 2013 | - | 42.11%(-78.4%) |
| Mar 2013 | - | 195.31%(-16.0%) |
| Dec 2012 | - | 232.43%(-26.7%) |
| Sep 2012 | 288.73%(-54.9%) | 316.90%(-23.4%) |
| Jun 2012 | - | 413.66%(+27.9%) |
| Mar 2012 | - | 323.43%(-34.1%) |
| Dec 2011 | - | 490.72%(-38.5%) |
| Sep 2011 | 639.63%(+115.6%) | 798.00%(+27.4%) |
| Jun 2011 | - | 626.22%(+110.0%) |
| Mar 2011 | - | 298.17%(+42.2%) |
| Dec 2010 | - | 209.61%(+53.6%) |
| Sep 2010 | 296.70%(+108.1%) | 136.46%(+18.0%) |
| Jun 2010 | - | 115.62%(-12.6%) |
| Mar 2010 | - | 132.30%(-6.5%) |
| Dec 2009 | - | 141.56%(-19.5%) |
| Sep 2009 | 142.55%(-38.9%) | 175.80%(-13.8%) |
| Jun 2009 | - | 203.90%(-14.6%) |
| Mar 2009 | - | 238.72%(-13.8%) |
| Dec 2008 | - | 276.98%(-31.6%) |
| Sep 2008 | 233.46%(-31.7%) | 405.15%(-20.6%) |
| Jun 2008 | - | 510.16%(-4.6%) |
| Mar 2008 | - | 534.53%(-22.7%) |
| Dec 2007 | - | 691.38%(+24.6%) |
| Sep 2007 | 341.62%(+107.6%) | 554.84%(+117.2%) |
| Jun 2007 | - | 255.49%(-17.2%) |
| Mar 2007 | - | 308.64%(+145.8%) |
| Dec 2006 | - | 125.55%(+17.8%) |
| Sep 2006 | 164.52%(-53.3%) | 106.56%(-54.0%) |
| Jun 2006 | - | 231.89%(-26.5%) |
| Mar 2006 | - | 315.50%(-34.7%) |
| Dec 2005 | - | 483.25%(-8.5%) |
| Sep 2005 | 352.31%(-726.3%) | 528.08% |
| Sep 2004 | -56.25% | - |
FAQ
- What is Anavex Life Sciences annual return on equity?
- What is the all time high annual ROE for Anavex Life Sciences?
- What is Anavex Life Sciences annual ROE year-on-year change?
- What is Anavex Life Sciences quarterly return on equity?
- What is the all time high quarterly ROE for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly ROE year-on-year change?
What is Anavex Life Sciences annual return on equity?
The current annual ROE of AVXL is -35.76%
What is the all time high annual ROE for Anavex Life Sciences?
Anavex Life Sciences all-time high annual return on equity is 639.63%
What is Anavex Life Sciences annual ROE year-on-year change?
Over the past year, AVXL annual return on equity has changed by -2.27% (-6.78%)
What is Anavex Life Sciences quarterly return on equity?
The current quarterly ROE of AVXL is -33.04%
What is the all time high quarterly ROE for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly return on equity is 798.00%
What is Anavex Life Sciences quarterly ROE year-on-year change?
Over the past year, AVXL quarterly return on equity has changed by -2.40% (-7.83%)